Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype von Harano, Kenichi, Wang, Ying, Lim, Bora, Seitz, Robert S, Morris, Stephan W, Bailey, Daniel B, Hout, David R, Skelton, Rachel L, Ring, Brian Z, Masuda, Hiroko, Rao, Arvind U K, Laere, Steven Van, Bertucci, Francois, Woodward, Wendy A, Reuben, James M, Krishnamurthy, Savitri, Ueno, Naoto T

Volltext

A Novel Monoclonal Antibody Against DOG1 is a Sensitive and Specific Marker for Gastrointestinal Stromal Tumors von ESPINOSA, Inigo, LEE, Cheng-Han, ZHONG WANG, RUBIN, Brian, NIELSEN, Torsten O, SEITZ, Robert S, ROSS, Douglas T, WEST, Robert B, CLEARY, Michael L, VAN DE RIJN, Matt, MI KYUNG KIM, ROUSE, Bich-Tien, SUBRAMANIAN, Subbaya, MONTGOMERY, Kelli, VARMA, Sushama, CORLESS, Christopher L, HEINRICH, Michael C, SMITH, Kevin S

Volltext

Association of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer von Ranganath, Harsha, Jain, Amit L, Smith, Justin R, Ryder, Julie, Chaudry, Amina, Miller, Emily, Hare, Felicia, Valasareddy, Poojitha, Seitz, Robert S, Hout, David R, Varga, Matthew G, Schweitzer, Brock L, Nielsen, Tyler J, Mullins, Janice, Ross, Douglas T, Gandara, David R, Vidal, Gregory A

Volltext

Translation of the 27-gene immuno-oncology test (IO score) to predict outcomes in immune checkpoint inhibitor treated metastatic urothelial cancer patients von Seitz, Robert S, Hurwitz, Michael E, Nielsen, Tyler J, Bailey, Daniel B, Varga, Matthew G, Ring, Brian Z, Metts, Carrie F, Schweitzer, Brock L, McGregor, Kimberly, Ross, Douglas T

Volltext

Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue von Jovanović, Bojana, Sheng, Quanhu, Seitz, Robert S, Lawrence, Kasey D, Morris, Stephan W, Thomas, Lance R, Hout, David R, Schweitzer, Brock L, Guo, Yan, Pietenpol, Jennifer A, Lehmann, Brian D

Volltext

A novel immuno-oncology algorithm measuring tumor microenvironment to predict response to immunotherapies von Nielsen, Tyler J., Ring, Brian Z., Seitz, Robert S., Hout, David R., Schweitzer, Brock L.

Volltext

A novel five-antibody immunohistochemical test for subclassification of lung carcinoma von Ring, Brian Z, Seitz, Robert S, Beck, Rodney A, Shasteen, William J, Soltermann, Alex, Arbogast, Stefanie, Robert, Francisco, Schreeder, Marshall T, Ross, Douglas T

Volltext

Mammostrat As an Immunohistochemical Multigene Assay for Prediction of Early Relapse Risk in the Tamoxifen Versus Exemestane Adjuvant Multicenter Trial Pathology Study von BARTLETT, John M. S, BLOOM, Kenneth J, KIEBACK, Dirk, PUTTER, Hein, MARKOPOULOS, Christos, DIRIX, Luc, SEYNAEVE, Caroline, REA, Daniel, PIPER, Tammy, LAWTON, Thomas J, DE VELDE, Cornelis J. H. Van, ROSS, Douglas T, RING, Brian Z, SEITZ, Robert S, BECK, Rodney A, HASENBURG, Annette

Volltext

Novel Prognostic Immunohistochemical Biomarker Panel for Estrogen Receptor–Positive Breast Cancer von RING, Brian Z, SEITZ, Robert S, ESTOPINAL, Noel C, ROSS, Douglas T, BECK, Rod, SHASTEEN, William J, TARR, Shannon M, CHEANG, Maggie C. U, YODER, Brian J, BUDD, G. Thomas, NIELSEN, Torsten O, HICKS, David G

Volltext

Mammostrat as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy von Bartlett, John M S, Thomas, Jeremy, Ross, Douglas T, Seitz, Robert S, Ring, Brian Z, Beck, Rodney A, Pedersen, Hans Christian, Munro, Alison, Kunkler, Ian H, Campbell, Fiona M, Jack, Wilma, Kerr, Gillian R, Johnstone, Laura, Cameron, David A, Chetty, Udi

Volltext

Spatial predictors of immunotherapy response in triple-negative breast cancer von Wang, Xiao Qian, Danenberg, Esther, Huang, Chiun-Sheng, Egle, Daniel, Callari, Maurizio, Bermejo, Begoña, Dugo, Matteo, Zamagni, Claudio, Thill, Marc, Anton, Anton, Zambelli, Stefania, Russo, Stefania, Ciruelos, Eva Maria, Greil, Richard, Győrffy, Balázs, Semiglazov, Vladimir, Colleoni, Marco, Kelly, Catherine M., Mariani, Gabriella, Del Mastro, Lucia, Biasi, Olivia, Seitz, Robert S., Valagussa, Pinuccia, Viale, Giuseppe, Gianni, Luca, Bianchini, Giampaolo, Ali, H. Raza

Volltext

Characterization of the tumor immune-microenvironment of adenocarcinoma of lung with a metastatic lesion in the pancreas treated successfully with first-line, single-agent pembroli... von Saltman, David L., Nielsen, Tyler J., Salina, Davide, Hout, David R., McMahon, Frank B., Valev, Boris R., Huk, Michael, Chandra, Pranil K., Spille, Jeremy, Seitz, Robert S., Schweitzer, Brock L.

Volltext

A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer von Page, David B., Pucilowska, Joanna, Chun, Brie, Kim, Isaac, Sanchez, Katherine, Moxon, Nicole, Mellinger, Staci, Wu, Yaping, Koguchi, Yoshinobu, Conrad, Valerie, Redmond, William L., Martel, Maritza, Sun, Zhaoyu, Campbell, Mary B., Conlin, Alison, Acheson, Anupama, Basho, Reva, McAndrew, Philomena, El-Masry, Mary, Park, Dorothy, Bennetts, Laura, Seitz, Robert S., Nielsen, Tyler J., McGregor, Kimberly, Rajamanickam, Venkatesh, Bernard, Brady, Urba, Walter J., McArthur, Heather L.

Volltext

Chemosensitivity and Stratification by a Five Monoclonal Antibody Immunohistochemistry Test in the NSABP B14 and B20 Trials von Ross, Douglas T, Kim, Chung-Yeul, Tang, Gong, Bohn, Olga L, Beck, Rodney A, Ring, Brian Z, Seitz, Robert S, Paik, Soonmyung, Costantino, Joseph P, Wolmark, Norman

Volltext

The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrence von Hicks, David G, Janarthanan, Bagi R, Vardarajan, Ramya, Kulkarni, Swati A, Khoury, Thaer, Dim, Daniel, Budd, G Thomas, Yoder, Brian J, Tubbs, Raymond, Schreeder, Marshall T, Estopinal, Noel C, Beck, Rodney A, Wang, Yanling, Ring, Brian Z, Seitz, Robert S, Ross, Douglas T

Volltext

Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients von Ring, Brian Z, Hout, David R, Morris, Stephan W, Lawrence, Kasey, Schweitzer, Brock L, Bailey, Daniel B, Lehmann, Brian D, Pietenpol, Jennifer A, Seitz, Robert S

Volltext

The 27-gene IO score is associated with efficacy of PD-1/L1 inhibitors independent of FGFR expression in a real-world metastatic urothelial carcinoma cohort von Nielsen, Tyler J., Varga, Matthew G., Cronister, Catherine T., Ring, Brian Z., Seitz, Robert S., Ross, Douglas T., Schweitzer, Brock L., McGregor, Kimberly

Volltext

TLE3 as a candidate biomarker of response to taxane therapy von Kulkarni, Swati A, Hicks, David G, Watroba, Nancy L, Murekeyisoni, Christine, Hwang, Helena, Khoury, Thaer, Beck, Rodney A, Ring, Brian Z, Estopinal, Noel C, Schreeder, Marshall T, Seitz, Robert S, Ross, Douglas T

Volltext

27-gene Immuno-Oncology (IO) Score is Associated With Efficacy of Checkpoint Immunotherapy in Advanced NSCLC: A Retrospective BC Cancer Study von Saltman, David L., Varga, Matthew G., Nielsen, Tyler J., Croteau, Nicole S., Lockyer, Heather M., Jain, Amit L., Vidal, Gregory A., Hout, David R., Schweitzer, Brock L., Seitz, Robert S., Ross, Douglas T., Gandara, David R.

Volltext

Gene expression patterns within cell lines are predictive of chemosensitivity von Ring, Brian Z, Chang, Stella, Ring, L Winston, Seitz, Robert S, Ross, Douglas T

Volltext